Rantika Silfarohana, Kuncara Nata Waskita, Nurul Hidayatul Mar'ah, Muhammad Saifur Rohman, Rizal Maarif Rukmana
{"title":"Investigating the Potential Synergistic Effects of Turmeric Extract and Black Rice Bran as Cytotoxic Agents Against HeLa Cells.","authors":"Rantika Silfarohana, Kuncara Nata Waskita, Nurul Hidayatul Mar'ah, Muhammad Saifur Rohman, Rizal Maarif Rukmana","doi":"10.31557/APJCP.2025.26.3.1059","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the synergistic effect of extract combinations from turmeric and black rice bran extract as anticancer agents on HeLa cells.</p><p><strong>Methods: </strong>Turmeric and black rice bran extracts were obtained by maceration with 96% ethanol. To determine the IC50 and combination index values, the cytotoxic assay of the extracts on HeLa cells was evaluated using the MTT assay, individually or in combination. The LC-HRMS analysis was employed to profile each extract.</p><p><strong>Result: </strong>Turmeric and black rice bran extracts yielded 23.29% and 7.57%, respectively, and LC-HRMS revealed that turmeric extract has the most ar-turmerone at 10.4%. In contrast, black rice bran extract contains many fatty acid derivative compounds. The MTT assay showed that turmeric extract had an IC50 value of 54 µg/mL against HeLa cells, while black rice bran extract had an IC50 value of 446 µg/mL. Combining ½ IC50 of turmeric extract and ½ IC50 of black rice bran extract has a synergistic effect, resulting in a lower viable cell population of 43.04% compared to the individual treatment of turmeric and black rice bran extract, which resulted in 96.92% and 79.30%, respectively.</p><p><strong>Conclusion: </strong>This study showed that a combination of turmeric and black rice bran exhibits greater cytotoxic activity than the individual extracts, promising an alternative anticancer treatment, particularly for cervical cancer.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"26 3","pages":"1059-1067"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12174512/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2025.26.3.1059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study aimed to evaluate the synergistic effect of extract combinations from turmeric and black rice bran extract as anticancer agents on HeLa cells.
Methods: Turmeric and black rice bran extracts were obtained by maceration with 96% ethanol. To determine the IC50 and combination index values, the cytotoxic assay of the extracts on HeLa cells was evaluated using the MTT assay, individually or in combination. The LC-HRMS analysis was employed to profile each extract.
Result: Turmeric and black rice bran extracts yielded 23.29% and 7.57%, respectively, and LC-HRMS revealed that turmeric extract has the most ar-turmerone at 10.4%. In contrast, black rice bran extract contains many fatty acid derivative compounds. The MTT assay showed that turmeric extract had an IC50 value of 54 µg/mL against HeLa cells, while black rice bran extract had an IC50 value of 446 µg/mL. Combining ½ IC50 of turmeric extract and ½ IC50 of black rice bran extract has a synergistic effect, resulting in a lower viable cell population of 43.04% compared to the individual treatment of turmeric and black rice bran extract, which resulted in 96.92% and 79.30%, respectively.
Conclusion: This study showed that a combination of turmeric and black rice bran exhibits greater cytotoxic activity than the individual extracts, promising an alternative anticancer treatment, particularly for cervical cancer.
期刊介绍:
Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.
The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally.
The APJCP publishes original research results under the following categories:
-Epidemiology, detection and screening.
-Cellular research and bio-markers.
-Identification of bio-targets and agents with novel mechanisms of action.
-Optimal clinical use of existing anti-cancer agents, including combination therapies.
-Radiation and surgery.
-Palliative care.
-Patient adherence, quality of life, satisfaction.
-Health economic evaluations.